MMP9 and stroke disorder: Our present findings suggest that the combined protein and mRNA expression of MMP-9 may be a useful biomarker for cognitive improvement in post-stroke patients, assuming an increase of three points on the MMSE scale, and that this test offers 87% sensitivity and 71% specificity (Figure 3A).